Cumulative incidence of VTE in patients with blood type O (n = 653) and non-O (n = 1055) divided in intermediate/low-risk and high-risk tumor types at 3-, 6-, 12-, and 24-month follow-up
| . | Cumulative VTE-incidence (%) [95% confidence interval] . | |||
|---|---|---|---|---|
| 3 mo . | 6 mo . | 12 mo . | 24 mo . | |
| Overall | ||||
| Blood type O | 3.8 [2.5-5.5] | 5.7 [4.1-7.7] | 7.0 [5.1-9.1] | 7.6 [5.7-9.9] |
| Blood type non-O | 3.4 [2.4-4.7] | 6.5 [5.1-8.1] | 8.4 [6.8-10.2] | 10.2 [8.4-12-2] |
| Intermediate/ low-risk cancer types | ||||
| Blood type O | 2.4 [1.3-4.0] | 3.4 [2.0-5.2] | 4.6 [3.0-6.7] | 5.0 [3.3-7.1] |
| Blood type non-O | 3.0 [2.0-4.3] | 5.4 [4.0-7.1] | 6.8 [5.2-8.6] | 8.6 [6.8-10.6] |
| High-risk cancer types | ||||
| Blood type O | 9.2 [5.0-14.9] | 14.7 [9.2-21.3] | 16.2 [10.5-23.1] | 17.9 [11.8-24.9] |
| Blood type non-O | 5.2 [2.7-9.0] | 11.1 [7.1-16.0] | 15.5 [10.7-21.1] | 17.3 [12.3-23.1] |
| . | Cumulative VTE-incidence (%) [95% confidence interval] . | |||
|---|---|---|---|---|
| 3 mo . | 6 mo . | 12 mo . | 24 mo . | |
| Overall | ||||
| Blood type O | 3.8 [2.5-5.5] | 5.7 [4.1-7.7] | 7.0 [5.1-9.1] | 7.6 [5.7-9.9] |
| Blood type non-O | 3.4 [2.4-4.7] | 6.5 [5.1-8.1] | 8.4 [6.8-10.2] | 10.2 [8.4-12-2] |
| Intermediate/ low-risk cancer types | ||||
| Blood type O | 2.4 [1.3-4.0] | 3.4 [2.0-5.2] | 4.6 [3.0-6.7] | 5.0 [3.3-7.1] |
| Blood type non-O | 3.0 [2.0-4.3] | 5.4 [4.0-7.1] | 6.8 [5.2-8.6] | 8.6 [6.8-10.6] |
| High-risk cancer types | ||||
| Blood type O | 9.2 [5.0-14.9] | 14.7 [9.2-21.3] | 16.2 [10.5-23.1] | 17.9 [11.8-24.9] |
| Blood type non-O | 5.2 [2.7-9.0] | 11.1 [7.1-16.0] | 15.5 [10.7-21.1] | 17.3 [12.3-23.1] |